Rhoifolin and cosmosiin exerted antidiabetic effects by promoting adiponectin secretion, the tyrosine phosphorylation of IR-β, and glucose transporter 4 (GLUT4) translocation. These bioactive molecules may help in insulin resistance-related treatment for diabetic complications. The gene discussed is SLC2A4; the disease is Insulin resistance.